#6 – Tazobactam and Tulips: Hot Topics from ECCMID 2019

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST. CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial. Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Episode metadata supplied by the publisher feed · Published Jul 10, 2019

Embed this episode

Attribution link and audio player

Ready to play

#6 – Tazobactam and Tulips: Hot Topics from ECCMID 2019

0:00 30:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakpoints?

This episode is 30 minutes long.

When was this Breakpoints episode published?

This episode was published on July 10, 2019.

Can I download this Breakpoints episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!